Cargando…

Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

AIMS/HYPOTHESIS: Diabetes treatments were related with either an increased or reduced risk of cancer. There is ongoing debate about a potential protective action of metformin. To summarize evidence on the association between metformin and risk of cancer and cancer mortality in patients with diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franciosi, Monica, Lucisano, Giuseppe, Lapice, Emanuela, Strippoli, Giovanni F. M., Pellegrini, Fabio, Nicolucci, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732236/ https://www.ncbi.nlm.nih.gov/pubmed/23936520 http://dx.doi.org/10.1371/journal.pone.0071583

Ejemplares similares

Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
por: Ceriello, Antonio, et al.
Publicado: (2021)

Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative
por: Russo, Giuseppina T., et al.
Publicado: (2022)

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
por: De Berardis, Giorgia, et al.
Publicado: (2009)

Benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study: protocol, tools, and population
por: Nicolucci, Antonio, et al.
Publicado: (2014)

Quality of Diabetes Care Predicts the Development of Cardiovascular Events: Results of the AMD-QUASAR Study
por: Rossi, Maria C.E., et al.
Publicado: (2011)

Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial
por: Saglimbene, Valeria, et al.
Publicado: (2017)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514–519
por: Ceriello, Antonio, et al.
Publicado: (2020)

Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393
por: Lapice, Emanuela, et al.
Publicado: (2013)

Therapy of Type 2 diabetes: more gliflozines and less metformin?
por: Verdecchia, Paolo, et al.
Publicado: (2023)

Sex Disparities in the Quality of Diabetes Care: Biological and Cultural Factors May Play a Different Role for Different Outcomes: A cross-sectional observational study from the AMD Annals initiative
por: Rossi, Maria Chiara, et al.
Publicado: (2013)

Common genetic variants on chromosome 9p21 are associated with myocardial infarction and type 2 diabetes in an Italian population
por: Gori, Francesca, et al.
Publicado: (2010)

Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study
por: Ferrito, Lucia, et al.
Publicado: (2019)

Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus
por: Russo, Giuseppina, et al.
Publicado: (2015)

Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
por: Ragonese, Mauro, et al.
Publicado: (2020)

The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level
por: Robusto, Fabio, et al.
Publicado: (2016)

β2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus
por: Pinelli, Michele, et al.
Publicado: (2006)

The complex interplay between clinical and person-centered diabetes outcomes in the two genders
por: Rossi, Maria Chiara, et al.
Publicado: (2017)

Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
por: Penno, Giuseppe, et al.
Publicado: (2021)

Antiplatelet Therapy for Every Diabetic Person?
por: Nicolucci, Antonio, et al.
Publicado: (2011)

Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk
por: Miele, Luca, et al.
Publicado: (2015)

The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes
por: Lapice, Emanuela, et al.
Publicado: (2015)

Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative
por: Manicardi, Valeria, et al.
Publicado: (2016)

Effect of a Behavioural Intervention for Adoption and Maintenance of a Physically Active Lifestyle on Psychological Well-Being and Quality of Life in Patients with Type 2 Diabetes: The IDES_2 Randomized Clinical Trial
por: Nicolucci, Antonio, et al.
Publicado: (2021)

Association between On-Treatment Haemoglobin A(1c) and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment
por: Orsi, Emanuela, et al.
Publicado: (2020)

Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes
por: Orsi, Emanuela, et al.
Publicado: (2022)

Uncoupling protein 2 G(-866)A polymorphism: a new gene polymorphism associated with C-reactive protein in type 2 diabetic patients C-reactive protein in type 2 diabetic patients
por: Lapice, Emanuela, et al.
Publicado: (2010)

Supervised Exercise Training Counterbalances the Adverse Effects of Insulin Therapy in Overweight/Obese Subjects With Type 2 Diabetes
por: Balducci, Stefano, et al.
Publicado: (2012)

Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
por: Penno, Giuseppe, et al.
Publicado: (2020)

Impact of chronic diuretic treatment on glucose homeostasis
por: Buscemi, Silvio, et al.
Publicado: (2013)

Metformin and the Risk of Dementia in Type 2 Diabetes Patients
por: Chin-Hsiao, Tseng
Publicado: (2019)

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study
por: Solini, Anna, et al.
Publicado: (2019)

The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
por: Ceriello, Antonio, et al.
Publicado: (2023)

A new perspective on metformin therapy in type 1 diabetes
por: Livingstone, Rachel, et al.
Publicado: (2017)

Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study
por: Orsi, Emanuela, et al.
Publicado: (2021)

Diverging Association of Reduced Glomerular Filtration Rate and Albuminuria With Coronary and Noncoronary Events in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
por: Solini, Anna, et al.
Publicado: (2012)

Habitual fish intake and clinically silent carotid atherosclerosis
por: Buscemi, Silvio, et al.
Publicado: (2014)

Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
por: Hou, Yi-Chao, et al.
Publicado: (2016)

Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus
por: Li, Tian, et al.
Publicado: (2021)

Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ip3ebqg9t1u5sd8pmip1o8dbsh